Ferreira Helena Beatriz, Trindade Fábio, Nogueira-Ferreira Rita, Leite-Moreira Adelino, Ferreira Rita, Dias-Neto Marina, Domingues M Rosário
Mass Spectrometry Center, LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Campus Universitário de Santiago, 3810-193, Aveiro, Portugal.
RISE-Health, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal.
J Mol Med (Berl). 2025 Apr;103(4):365-380. doi: 10.1007/s00109-025-02524-1. Epub 2025 Feb 26.
Abdominal aortic aneurysm (AAA) and peripheral arterial disease (PAD) are two cardiovascular diseases associated with considerable morbidity, mortality and quality of life impairment. As they are multifactorial diseases, several factors contribute to their pathogenesis, including oxidative stress and lipid peroxidation, and these may have key roles in the development of these pathologies. Alterations of the lipid metabolism and lipid profile have been reported in cardiovascular diseases but to a lesser extent in AAA and PAD. Modifications in the profile of some molecular lipid species, in particular, native phospholipid and triglyceride species were mainly reported for AAA, while alterations in the fatty acid profile were noticed in the case of PAD. Oxidized phospholipids were also reported for AAA. Although AAA and PAD have a common atherosclerotic root, lipidomics demonstrates the existence of distinct lipid. Lipidomic research regarding AAA and PAD is still scarce and should be set in motion to increase the knowledge on the lipid changes that occur in these diseases, contributing not only to the discovery of new biomarkers for diagnosis and prognosis assessment but also to tailor precision medicine in the clinical field.
腹主动脉瘤(AAA)和外周动脉疾病(PAD)是两种与高发病率、死亡率及生活质量受损相关的心血管疾病。由于它们是多因素疾病,多种因素参与其发病机制,包括氧化应激和脂质过氧化,这些因素可能在这些疾病的发展中起关键作用。脂质代谢和血脂谱的改变在心血管疾病中已有报道,但在腹主动脉瘤和外周动脉疾病中报道较少。特别是,一些分子脂质种类的变化,主要是天然磷脂和甘油三酯种类的变化,在腹主动脉瘤中报道较多,而在外周动脉疾病中则发现脂肪酸谱有改变。氧化磷脂在腹主动脉瘤中也有报道。虽然腹主动脉瘤和外周动脉疾病有共同的动脉粥样硬化根源,但脂质组学表明存在不同的脂质。关于腹主动脉瘤和外周动脉疾病的脂质组学研究仍然很少,应该启动这方面的研究,以增加对这些疾病中发生的脂质变化的了解,这不仅有助于发现用于诊断和预后评估的新生物标志物,还能为临床领域的精准医疗提供依据。